Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to BrainXell in September, 2019 for $699,736.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DA042659-02 | Phase II | 699,736 | September 15, 2019 | |||||||
A SBIR Phase I contract was awarded to BrainXell in September, 2019 for $224,797.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43NS112047-01 | Phase I | 224,797 | September 1, 2019 | |||||||
A SBIR Phase I contract was awarded to BrainXell in May, 2021 for $255,217.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AG073055-01 | Phase I | 255,217 | May 1, 2021 | |||||||
A SBIR Phase I contract was awarded to BrainXell in September, 2016 for $202,277.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS097080-01A1 | Phase I | 202,277 | September 1, 2016 | |||||||
A SBIR Phase II contract was awarded to BrainXell in September, 2017 for $1,451,944.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44MH110301-02 | Phase II | 1,451,944 | September 6, 2017 | |||||||
A SBIR Phase I contract was awarded to BrainXell in September, 2016 for $220,391.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DA042659-01 | Phase I | 220,391 | September 1, 2016 | |||||||
A SBIR Phase I contract was awarded to BrainXell in April, 2016 for $221,677.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43MH110301-01 | Phase I | 221,677 | April 1, 2016 | |||||||
A SBIR Phase I contract was awarded to BrainXell in August, 2023 for $275,615.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43MH135527-01 | Phase I | 275,615 | August 17, 2023 |